Prostate Cancer

In this video, Mark T. Fleming, MD, discusses results from the SPOTLIGHT study, which he presented at this year’s American Urological Association meeting.

In this video, Kara N. Babaian, MD, highlighted three presentations from the American Urological Association meeting that reported on salvage treatment following focal therapy.

In this video, Kara N. Babaian, MD, spoke with Healio about a presentation on patient-reported outcomes after radical prostatectomy for high-risk prostate cancer from the American Urological Association meeting.

A systematic review of 31 studies showed favorable results supporting the incorporation of a plant-based diet for men at risk for or diagnosed with prostate cancer.

A deep-learning algorithm detected prostate lesions on multiparametric MRI and tracked lesions throughout the disease course among a subset of patients on active surveillance for prostate cancer, according to study results.

Black veterans had a nearly twofold higher incidence of both localized prostate cancer and de novo metastatic disease compared with white veterans, according to a nationwide, retrospective cohort study published in JAMA Network Open.

William L. Dahut, MD, has been named chief scientific officer of American Cancer Society.

Novartis temporarily suspended production at two of its radioligand therapy production sites.

The FDA granted priority review to darolutamide in combination with docetaxel for treatment of metastatic hormone-sensitive prostate cancer.

Plinabulin demonstrated similar efficacy to pegfilgrastim for the prevention of chemotherapy-induced neutropenia, according to results of a randomized phase 3 study published in JAMA Network Open.